We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+4.83%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$46B
AUM Growth
+$2.18B
Cap. Flow
+$425M
Cap. Flow %
0.92%
Top 10 Hldgs %
15.17%
Holding
2,954
New
28
Increased
2,252
Reduced
604
Closed
50

Top Buys

Rank Stock Value
1
DD icon
DuPont de Nemours
DD
+$128M
2
BKR icon
Baker Hughes
BKR
+$26.7M
3
IQV icon
IQVIA
IQV
+$14.5M
4
OKE icon
Oneok
OKE
+$14.3M
5
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$11.2M

Sector Composition

Rank Sector Weight
1 Financials 16.64%
2 Technology 15.8%
3 Healthcare 13.57%
4 Industrials 10.87%
5 Consumer Discretionary 9.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TMO icon
76
Thermo Fisher Scientific
TMO
$208B
$117M 0.25%
618,514
+20,031
+3% +$3.63M
CB icon
77
Chubb
CB
$139B
$115M 0.25%
806,893
-1,450
-0.2% -$210K
PNC icon
78
PNC Financial Services
PNC
$99.6B
$114M 0.25%
847,623
+6,993
+0.8% +$897K
MS icon
79
Morgan Stanley
MS
$337B
$114M 0.25%
2,360,332
+2,260
+0.1% +$105K
AMT icon
80
American Tower
AMT
$77.7B
$110M 0.24%
807,253
+5,731
+0.7% +$798K
COP icon
81
ConocoPhillips
COP
$141B
$109M 0.24%
2,184,083
-5,730
-0.3% -$257K
CAT icon
82
Caterpillar
CAT
$402B
$108M 0.24%
869,803
-2,529
-0.3% -$291K
AGN
83
DELISTED
Allergan plc
AGN
$107M 0.23%
521,276
+7,500
+1% +$1.74M
MDLZ icon
84
Mondelez International
MDLZ
$77.9B
$107M 0.23%
2,624,829
-3,323
-0.1% -$141K
BIIB icon
85
Biogen
BIIB
$29.5B
$106M 0.23%
339,077
+3,821
+1% +$1.13M
BLK icon
86
Blackrock
BLK
$165B
$105M 0.23%
234,148
+2,568
+1% +$1.1M
DUK icon
87
Duke Energy
DUK
$100B
$103M 0.22%
1,230,313
+8,309
+0.7% +$711K
SPG icon
88
Simon Property Group
SPG
$75.1B
$101M 0.22%
629,764
+10,534
+2% +$1.68M
CRM icon
89
Salesforce
CRM
$142B
$101M 0.22%
1,085,077
+18,452
+2% +$1.7M
EOG icon
90
EOG Resources
EOG
$74.7B
$100M 0.22%
1,035,849
+20,365
+2% +$1.84M
AET
91
DELISTED
Aetna Inc
AET
$99.4M 0.22%
625,174
+18,901
+3% +$2.95M
AIG icon
92
American International
AIG
$42B
$96.3M 0.21%
1,569,329
+11,801
+0.8% +$735K
FDX icon
93
FedEx
FDX
$73.5B
$95.7M 0.21%
424,412
+5,245
+1% +$1.12M
DHR icon
94
Danaher
DHR
$138B
$95.7M 0.21%
1,257,938
+61,595
+5% +$4.56M
ELV icon
95
Elevance Health
ELV
$82.1B
$94.7M 0.21%
498,774
-3,549
-0.7% -$675K
RTN
96
DELISTED
Raytheon Company
RTN
$93.8M 0.2%
502,665
+3,070
+0.6% +$541K
BNY
97
Bank of New York Mellon
BNY
$107B
$92.6M 0.2%
1,746,821
+16,839
+1% +$884K
SYK icon
98
Stryker
SYK
$129B
$92.3M 0.2%
649,696
+46,914
+8% +$6.73M
ADP icon
99
Automatic Data Processing
ADP
$102B
$91.1M 0.2%
833,613
+16,396
+2% +$1.76M
MON
100
DELISTED
Monsanto Co
MON
$91M 0.2%
759,750
+13,334
+2% +$1.57M

Similar funds

RhumbLine Advisers's Q3 2017 Portfolio in Review

As of Q3 2017, RhumbLine Advisers held 2,954 positions worth $46B, up 5% from $43.8B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Trading was light in Q3 2017: portfolio turnover was 2.6%. RhumbLine Advisers opened 28 new positions and exited 50, leaving the 2,954-position portfolio largely intact.

By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.

  • RhumbLine Advisers's largest Q3 2017 buy was Baker Hughes: 750,985 shares worth $27.5M.
  • RhumbLine Advisers added most to DuPont de Nemours in Q3 2017, an estimated $128M increase.
  • RhumbLine Advisers's biggest Q3 2017 reduction was UnitedHealth, cutting an estimated $22.8M.
  • RhumbLine Advisers fully exited Du Pont De Nemours E I in Q3 2017, selling an estimated $114M.
  • RhumbLine Advisers's ten largest holdings make up 15% of its $46B portfolio in Q3 2017.
  • RhumbLine Advisers opened 28 new positions and closed 50 in Q3 2017.
  • RhumbLine Advisers's portfolio value rose 5% quarter-over-quarter to $46B.

Based on RhumbLine Advisers's 13F filing for Q3 2017, filed 6 Nov 2017.